Skip to main content

Bleeding Cirrhotic Patients: Endoscopic Therapy

  • Chapter
  • First Online:
Multidisciplinary Approaches to Common Surgical Problems
  • 538 Accesses

Abstract

Gastrointestinal (GI) hemorrhage is a serious medical condition commonly encountered in patients with cirrhosis. The etiology of bleeding is often grouped into causes proximal to the ligament of Treitz (upper GI bleed) or beyond it (lower GI bleed). Patients with cirrhosis are significantly more likely to present with upper GI bleed, which carries a higher risk of mortality. Gastrointestinal hemorrhage in cirrhosis is often driven by portal hypertension, though it may arise from other causes. The goal of therapy is to prevent and correct shock by providing resuscitative and supportive measures alongside medical, interventional radiologic, and endoscopic therapies to prevent further bleeding and complications of bleeding. Medical team members must be able to recognize and treat a variety of presentations of gastrointestinal hemorrhage in the cirrhotic patient. This chapter will provide an overview of general principles of evaluation and treatment, with a focus on the endoscopic management of upper GI bleeding, particularly bleeding due to portal hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Sclerosing agents include sodium tetradecyl sulfate, sodium morrhuate, polidocanol, ethanolamine oleate, and ethanol.

  2. 2.

    Cyanoacrylate injection is not FDA approved, but is available at many tertiary centers in the United States. Injection may be performed with a standard upper endoscope or using endoscopic ultrasound.

References

  1. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med. 1988;319:983–9.

    Article  Google Scholar 

  2. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310–35.

    Article  Google Scholar 

  3. Kalafateli M, Triantos CK, Nikolopoulou V, Burroughs A. Non-variceal gastrointestinal bleeding in patients with liver cirrhosis: a review. Dig Dis Sci. 2012;57:2743–54.

    Article  CAS  Google Scholar 

  4. Hwang JH, Sergill AK, Chandrasekhara V, et al. The role of endoscopy in the management of variceal hemorrhage. Gastrointest Endosc. 2014;80(2):221–7.

    Article  Google Scholar 

  5. Cardenas A, Mendez-Bocanegra A. Report of the Baveno VI consensus workshop. Ann Hepatol. 2016;15:289–90.

    PubMed  Google Scholar 

  6. Hwang JH, Fisher DA, Ben-Menachem T, et al. The role of endoscopy in the manangement of acute non-variceal upper GI bleeding. Gastrointest Endosc. 2012;75:1132–68.

    Article  Google Scholar 

  7. Aljebreen AM, Fallone CA, Barkun AN. Nasogastric aspirate predicts high-risk endoscopic lesions in patients with acute upper-GI bleeding. Gastrointest Endosc. 2004;59:172–8.

    Article  Google Scholar 

  8. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368:11–21.

    Article  CAS  Google Scholar 

  9. Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol. 2013;11:1064–74.

    Article  Google Scholar 

  10. De Pietri L, Bianchini M, Montalti R, et al. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial. Hepatology. 2016;63:566–73.

    Article  Google Scholar 

  11. Haas T, Fries D, Tanaka KA, Asmis L, Curry NS, Schochl H. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? Br J Anaesth. 2015;114:217–24.

    Article  CAS  Google Scholar 

  12. Basili S, Raparelli V, Napoleone L, et al. Platelet count does not predict bleeding in cirrhotic patients: results from the PRO-LIVER study. Am J Gastroenterol. 2018;113:368–75.

    Article  CAS  Google Scholar 

  13. Seo YS, Park SY, Kim MY, et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology. 2014;60:954–63.

    Article  CAS  Google Scholar 

  14. Wells M, Chande N, Adams P, et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther. 2012;35:1267–78.

    Article  CAS  Google Scholar 

  15. Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29:1655–61.

    Article  CAS  Google Scholar 

  16. Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, Boccia S, Colloredo-Mels G, Corigliano P, Fornaciari G, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis. 2001;33:41–8.

    Article  CAS  Google Scholar 

  17. Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, et al. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review. Aliment Pharmacol Ther. 2011;34:509–18.

    Article  CAS  Google Scholar 

  18. Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila FI, Soares-Weiser K, Uribe M. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2010;9:CD002907.

    Google Scholar 

  19. Soares-Weiser K, Brezis M, Tur-Kaspa R, Leibovici L. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev. 2002;(2):CD002907.

    Google Scholar 

  20. Sreedharan A, Martin J, Leontiadis GI, et al. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2010;(7):CD005415.

    Google Scholar 

  21. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials. Mayo Clin Proc. 2007;82:286–96.

    Article  CAS  Google Scholar 

  22. Shaheen NJ, Stuart E, Schmitz SM, et al. Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology. 2005;41:588–94.

    Article  CAS  Google Scholar 

  23. Barkun AN, Bardou M, Martel M, Gralnek IM, Sung JJ. Prokinetics in acute upper GI bleeding: a meta-analysis. Gastrointest Endosc. 2010;72:1138–45.

    Article  Google Scholar 

  24. Chait MM. Lower gastrointestinal bleeding in patients with cirrhosis. Arch Dig Disord. 2017;1(1):14–21.

    Google Scholar 

  25. D’Amico G, de Franchis R, Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post‐therapeutic outcome and prognostic indicators. Hepatology. 2003;38:599–612.

    Article  Google Scholar 

  26. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40:652–9.

    Article  Google Scholar 

  27. Garcia-Tsao G, Lim JK, Members of Veterans Affairs Hepatitis CRCP. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009;104:1802–29.

    Article  Google Scholar 

  28. Lo GH, Lai KH, Cheng JS, et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology. 1995;22:466–71.

    Article  CAS  Google Scholar 

  29. Puente A, Hernandez‐Gea V, Graupera I, Roque M, Colomo A, Poca M, et al. Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review. Liver Int. 2014;34:823–33.

    Article  Google Scholar 

  30. Garcia-Pagan JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362:2370–9.

    Article  CAS  Google Scholar 

  31. Rudler M, Cluzel P, Corvec TL, et al. Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival. Aliment Pharmacol Ther. 2014;40:1074–80.

    Article  CAS  Google Scholar 

  32. Augustin S, Altamirano J, Gonzalez A, et al. Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding. Am J Gastroenterol. 2011;106:1787–95.

    Article  CAS  Google Scholar 

  33. Avgerinos A, Armonis A. Balloon tamponade technique and efficacy in variceal haemorrhage. Scand J Gastroenterol Suppl. 1994;207:11–6.

    Article  CAS  Google Scholar 

  34. Escorsell A, Pavel O, Cardenas A, et al. Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: a multicenter randomized, controlled trial. Hepatology. 2016;63:1957–67.

    Article  Google Scholar 

  35. Hubmann R, Bodlaj G, Czompo M, et al. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy. 2006;38:896–901.

    Article  CAS  Google Scholar 

  36. Gur I, Diggs BS, Orloff SL. Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant. HPB (Oxford). 2013;16(5):481–93.

    Article  Google Scholar 

  37. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992;16:1343–9.

    Article  CAS  Google Scholar 

  38. Rios Castellanos E, Seron P, Gisbert JP, Bonfill Cosp X. Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension. Cochrane Database Syst Rev. 2015;12(5):CD010180.

    Google Scholar 

  39. El Amin H, Abdel Baky L, Sayez Z, et al. A randomized trial of endoscopic variceal ligation versus cyanoacralate injection for treatment of bleeding junctional varices. Trop Gastroenterol. 2010;31(4):279–84.

    PubMed  Google Scholar 

  40. Sarin SK, Jain AK, Jain M, et al. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol. 2002;97:1010–5.

    Article  CAS  Google Scholar 

  41. Procaccini NJ, Al-Osaimi AM, Northup P, Argo C, Caldwell SH. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc. 2009;70:881–7.

    Article  Google Scholar 

  42. Saad WE. Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes. Semin Interv Radiol. 2012;29:118–28.

    Article  Google Scholar 

  43. Mishra SR, Chander SB, Kumar A, Sarin SK. Endoscopic cyanoacrylate injection versus beta‐blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Gut. 2010;59:729–35.

    Article  CAS  Google Scholar 

  44. Lo GH, Liang HL, Chen WC, Chen MH, Lai KH, Hsu PI, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy. 2007;39:679–85.

    Article  Google Scholar 

  45. Norton ID, Andrews JC, Kamath PS. Management of ectopic varices. Hepatology. 1998;28:1154–8.

    Article  CAS  Google Scholar 

  46. Zhou Y, Qiao L, Wu J, Hu H, Xu C. Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study. J Gastroenterol Hepatol. 2002;17:973–9.

    Article  CAS  Google Scholar 

  47. Perez-Ayuso RM, Pique JM, Bosch J, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet. 1991;337:1431–4.

    Article  CAS  Google Scholar 

  48. Kamath PS, Lacerda M, Ahlquist DA, McKusick MA, Andrews JC, Nagorney DA. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology. 2000;118:905–11.

    Article  CAS  Google Scholar 

  49. Hsu Y‐C, et al. Long‐term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10‐year nationwide cohort study. Hepatology. 2012;56(2):698–705.

    Article  Google Scholar 

  50. Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol. 2009;7:33–47.

    Article  Google Scholar 

  51. Javid G, Zargar SA, U-Saif R, et al. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastri c pH in bleeding peptic ulcer. J Gastroenterol Hepatol. 2009;24:1236–43.

    Article  CAS  Google Scholar 

  52. Pruitt RE, Truss CD. Endoscopy, gastric ulcer, and gastric cancer. Follow-up endoscopy for all gastric ulcers? Dig Dis Sci. 1993;38:284–8.

    Article  CAS  Google Scholar 

  53. Smith E, Tekola B, Patrie J, Cornella S, Caldwell S. Clinical characterization of gastric antral vascular ectasia: a potential manifestation of the metabolic syndrome. Am J Med. 2016;129(12):1329–e19.

    Article  Google Scholar 

  54. Cho S, Zanati S, Yong E, et al. Endoscopic cryotherapy for the management of gastric antral vascular ectasia. Gastrointest Endosc. 2008;68:895–902.

    Article  Google Scholar 

  55. Dulai GS, Jensen DM, Kovacs TO, Gralnek IM, Jutabha R. Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy. 2004;36:68–72.

    Article  CAS  Google Scholar 

  56. Herrera S, Bordas JM, Llach J, et al. The beneficial effects of argon plasma coagulation in the management of different types of gastric vascular ectasia lesions in patients admitted for GI hemorrhage. Gastrointest Endosc. 2008;68:440–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John H. Holden .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Holden, J.H., Bhatti, U.A. (2019). Bleeding Cirrhotic Patients: Endoscopic Therapy. In: Lim, R. (eds) Multidisciplinary Approaches to Common Surgical Problems. Springer, Cham. https://doi.org/10.1007/978-3-030-12823-4_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-12823-4_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-12822-7

  • Online ISBN: 978-3-030-12823-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics